| Literature DB >> 31940477 |
Gaëlle Cordonnier1, Amit Mandoli2, Nicolas Cagnard3, Guillaume Hypolite1, Ludovic Lhermitte1, Els Verhoeyen4, Vahid Asnafi1, Niall Dillon5, Elizabeth Macintyre1, Joost H A Martens2, Jonathan Bond6.
Abstract
Mutations and deletions of polycomb repressive complex (PRC) components are increasingly recognized to affect tumor biology in a range of cancers. However, little is known about how genetic alterations of PRC-interacting molecules such as the core binding factor (CBF) complex influence polycomb activity. We report that the acute myeloid leukemia (AML)-associated CBFβ-SMMHC fusion oncoprotein physically interacts with the PRC1 complex and that these factors co-localize across the AML genome in an apparently PRC2-independent manner. Depletion of CBFβ-SMMHC caused substantial increases in genome-wide PRC1 binding and marked changes in the association between PRC1 and the CBF DNA-binding subunit RUNX1. PRC1 was more likely to be associated with actively transcribed genes in CBFβ-SMMHC-expressing cells. CBFβ-SMMHC depletion had heterogeneous effects on gene expression, including significant reductions in transcription of ribosomal loci occupied by PRC1. Our results provide evidence that CBFβ-SMMHC markedly and diversely affects polycomb recruitment and transcriptional regulation across the AML genome.Entities:
Keywords: acute myeloid leukemia; core binding factor; epigenetic regulation; oncogene; polycomb
Year: 2020 PMID: 31940477 DOI: 10.1016/j.celrep.2019.12.026
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423